Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
Johnson & Johnson Vision Names Regional Presidents
Johnson & Johnson Vision has announced the appointment of Lori Tierney as President, Americas; Jacqueline Henderson as President, EMEA; and Christoph Vonwiller as President, Asia Pacific. Ms. Tierney brings her experience as the former President of Americas for the Vision…
WCO and Alcon to Launch Revolutionary Dry Eye Tool
The World Council of Optometry (WCO) and Alcon are extending an invitation to eye care professionals worldwide to join them at the launch of a new tool that aids in the diagnosis and treatment of dry eye disease. Interested parties…
Positive Results for Dry AMD Treatment by LumiThera
LumiThera announced the 24-month data from its LIGHTSITE III multicenter clinical trial. The results showed sustained vision improvement in subjects with dry age-related macular degeneration (AMD) who were treated with the Valeda Light Delivery System. LumiThera conducted LIGHTSITE III, a…
Gene Therapy for Retinitis Pigmentosa Shows Promise
People with retinitis pigmentosa typically experience changes in their vision during childhood or early adulthood. The condition commonly results in a decline in both peripheral and night vision, ultimately leading to blindness in the majority of cases. A team of…
Visionix Unveils VX 650 Multimodal Screener
Visionix has announced the release of the second generation of its VX 650 multimodal device. First launched in 2021, the VX 650 is an advanced anterior segment analyzer with retinal imaging capabilities. The updated version features an enhanced wavefront-based aberrometer…
Apellis’ Syfovre for Treatment of GA Approved by FDA
The FDA has approved Apellis Pharmaceuticals’ Syfovre (pegcetacoplan) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). This marks the first time that patients with GA have an FDA-approved treatment option, which is a significant milestone…
Benefits Of Combination Drops On Glaucoma Management
When patients are diagnosed with glaucoma, one of the most common treatment options is a prescription eye drop medication that lowers eye pressure, which prevents damage to the optic nerve and helps to preserve vision. Several types of drugs lower…
J&J announced new products at the AAO annual meeting
Johnson & Johnson Vision announced a series of new products and innovations at the 2019 American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, CA, USA. The company announced the US Food & Drug Administration (FDA) approval of the…
Updates On Central Serous Chorioretinopathy
Central serous chorioretinopathy, commonly referred to as CSC, is a condition in which fluid accumulates under the retina, causing a serous (fluid-filled) detachment and vision loss. CSC most often occurs in young and middle-aged adults. For unknown reasons, men develop…
Topcon and OphtAI Collaborate for AI Technology
Topcon Healthcare Solutions and OphtAI, a joint venture specialized in Artificial Intelligence (AI) for ophthalmology, have announced a partnership to integrate OphtAI into Topcon’s Harmony Referral System, and provide eye care professionals with smarter access to AI services. OphtAI’s state-of-the-art…